BioNTech SE is 3.3x more valuable than Vaxcyte, Inc. by market capitalization ($22.18 B vs $6.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PCVX | BNTX |
|---|---|---|
| Market cap | $6.81 B | $22.18 B |
| US-listed rank | #1179 | #582 |
| Net income (latest FY) | -$766.63K | - |
| SEC filings | 690 | 548 |
BioNTech SE is 3.3x more valuable than Vaxcyte, Inc. by market capitalization ($22.18 B vs $6.81 B).
Full pages: Vaxcyte, Inc. and BioNTech SE, or browse the full rankings.